OFF-BRAND GLEEVEC: A AFFORDABLE ALTERNATIVE?

The arrival of common imatinib represents a substantial chance for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, branded as Gleevec, carries a high price label, frequently presenting a challenge for accessibility for some individuals. Off-brand versi